Pharmaceutical
Pharmaceutical
The 340B Rebate Pause: Why Smart Systems are Still Preparing for Change
BY
Sean Gilman
For many hospitals, the 340B program is more than a regulatory framework, it is a financial stabilizer. The savings generated ...
Pharmaceutical
Why AI and Regulations Will Drive New Drug Development Strategies in 2026
BY
Jim Reilly
Large biopharmas and biotechs have advanced drug development operations by connecting data and processes across the product lifecycle to support ...
Pharmaceutical
When health systems integrate pharmacists into psychiatric care, adherence gaps close and patients benefit
BY
Dr. Alberto Augsten
Adherence to treatments and medications as prescribed is a challenge across diagnoses and clinical contexts. There probably isn’t a disease ...
Pharmaceutical
From AI to Tariffs: What 2025 Taught Healthcare & Pharma About the Year Ahead
BY
Michael K. Needham, PhD
2025 was a year defined by anticipation—a landscape shaped less by what happened and more by what people feared might ...
Pharmaceutical
Seeing the Whole Board: Why End-to-End Pharmacy Visibility is Now a Patient-Safety Imperative
BY
Dr. Valerie Bandy, PharmD, MBA
Hospital pharmacy has long managed what’s directly in front of it: the central pharmacy and, when bandwidth allows, some satellites. ...
